Absci is trading 10% up at $7.59 as the stock benefits from a strong risk-on rally across the tech and biotech sectors.
- The move follows a broader Nasdaq surge fueled by strong Microsoft earnings, which has boosted sentiment across growth-oriented industries.
- No fresh company-specific news or regulatory filings have been identified to explain today’s price action beyond general market momentum.